HUP0003396A3 - Somatostatin antagonist peptides - Google Patents
Somatostatin antagonist peptidesInfo
- Publication number
- HUP0003396A3 HUP0003396A3 HU0003396A HUP0003396A HUP0003396A3 HU P0003396 A3 HUP0003396 A3 HU P0003396A3 HU 0003396 A HU0003396 A HU 0003396A HU P0003396 A HUP0003396 A HU P0003396A HU P0003396 A3 HUP0003396 A3 HU P0003396A3
- Authority
- HU
- Hungary
- Prior art keywords
- antagonist peptides
- somatostatin antagonist
- somatostatin
- peptides
- antagonist
- Prior art date
Links
- 102000005157 Somatostatin Human genes 0.000 title 1
- 108010056088 Somatostatin Proteins 0.000 title 1
- 239000005557 antagonist Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- NHXLMOGPVYXJNR-ATOGVRKGSA-N somatostatin Chemical compound C([C@H]1C(=O)N[C@H](C(N[C@@H](CO)C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC=2C3=CC=CC=C3NC=2)C(=O)N[C@@H](CCCCN)C(=O)N[C@H](C(=O)N1)[C@@H](C)O)NC(=O)CNC(=O)[C@H](C)N)C(O)=O)=O)[C@H](O)C)C1=CC=CC=C1 NHXLMOGPVYXJNR-ATOGVRKGSA-N 0.000 title 1
- 229960000553 somatostatin Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/655—Somatostatins
- C07K14/6555—Somatostatins at least 1 amino acid in D-form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Emergency Medicine (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US3235896P | 1996-12-04 | 1996-12-04 | |
| US76067296A | 1996-12-04 | 1996-12-04 | |
| US08/855,204 US6262229B1 (en) | 1996-12-04 | 1997-05-13 | Somatostatin antagonists |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0003396A1 HUP0003396A1 (hu) | 2001-02-28 |
| HUP0003396A3 true HUP0003396A3 (en) | 2001-03-28 |
Family
ID=27364103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0003396A HUP0003396A3 (en) | 1996-12-04 | 1997-12-04 | Somatostatin antagonist peptides |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0956296B1 (hu) |
| JP (2) | JP4124820B2 (hu) |
| KR (1) | KR100479149B1 (hu) |
| AT (1) | ATE330966T1 (hu) |
| AU (1) | AU728224B2 (hu) |
| BR (1) | BR9714376A (hu) |
| CA (1) | CA2274144C (hu) |
| DE (1) | DE69736193T2 (hu) |
| ES (1) | ES2264174T3 (hu) |
| HU (1) | HUP0003396A3 (hu) |
| IL (1) | IL130166A0 (hu) |
| MX (1) | MXPA99004944A (hu) |
| NZ (1) | NZ335879A (hu) |
| PL (1) | PL334089A1 (hu) |
| RU (1) | RU2179172C2 (hu) |
| TW (1) | TW575582B (hu) |
| WO (1) | WO1998024807A2 (hu) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0011919A (pt) * | 1999-06-25 | 2002-03-19 | Sod Conseils Rech Applic | Agonistas de somatostatina |
| US6864234B1 (en) | 1999-06-25 | 2005-03-08 | Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. | Somatostatin agonists |
| RU2263678C2 (ru) | 2001-03-08 | 2005-11-10 | Дзе Администрейторс Оф Дзе Тьюлейн Эдьюкейшнл Фанд | Антагонисты соматостатина |
| KR20030088494A (ko) * | 2001-04-09 | 2003-11-19 | 더 어드미니스트레이터즈 오브 더 튜래인 어듀케이셔널 훤드 | 소마토스타틴 작용제 |
| US8691761B2 (en) | 2006-10-16 | 2014-04-08 | Jean E. F. Rivier | Somatostatin receptor 2 antagonists |
| CN101631801B (zh) * | 2006-10-16 | 2013-06-05 | 索尔克生物学研究院 | 受体（sstr2）-选择性生长抑素拮抗剂 |
| ES2351569B8 (es) * | 2009-05-07 | 2012-06-20 | Bcn Peptides S.A. | Ligandos peptídicos de receptores de somatostatina. |
| WO2011151782A1 (en) | 2010-06-02 | 2011-12-08 | Preglem Sa | A role for somatostatin to modulate initiation of follicular growth in the human ovary |
| EP2399931A1 (fr) * | 2010-06-22 | 2011-12-28 | Ipsen Pharma S.A.S. | Nouveaux composés octapeptidiques et leur utilisation thérapeutique |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT42101A (en) * | 1985-01-07 | 1987-06-29 | Sandoz Ag | Process for preparing stomatostatine derivatives and pharmaceutical compositions containing such compounds |
| US4904642A (en) * | 1985-09-12 | 1990-02-27 | The Administrators Of The Tulane Educational Fund | Therapeutic somatostatin analogs |
| US4853371A (en) * | 1986-06-17 | 1989-08-01 | The Administrators Of The Tulane Educational Fund | Therapeutic somatostatin analogs |
| US5073541A (en) * | 1987-11-18 | 1991-12-17 | Administrators Of The Tulane Educational Fund | Treatment of small cell lung cancer with somatostatin analogs |
| US5633263A (en) * | 1989-04-26 | 1997-05-27 | The Administrators Of The Tulane Educational Fund | Linear somatostatin analogs |
| JP2882679B2 (ja) * | 1989-04-26 | 1999-04-12 | ジ・アドミニストレーターズ・オブ・ザ・ツーレイン・エデュケイショナル・ファンド | 線状ソマトスタチン類似体 |
| US5708135A (en) * | 1995-09-29 | 1998-01-13 | Biomeasure Incorporated | Cyclic peptide analogs of somatostatin |
-
1997
- 1997-12-04 AU AU76248/98A patent/AU728224B2/en not_active Ceased
- 1997-12-04 HU HU0003396A patent/HUP0003396A3/hu unknown
- 1997-12-04 AT AT97949758T patent/ATE330966T1/de not_active IP Right Cessation
- 1997-12-04 TW TW86118262A patent/TW575582B/zh not_active IP Right Cessation
- 1997-12-04 MX MXPA99004944A patent/MXPA99004944A/es unknown
- 1997-12-04 IL IL13016697A patent/IL130166A0/xx unknown
- 1997-12-04 PL PL97334089A patent/PL334089A1/xx unknown
- 1997-12-04 KR KR10-1999-7004835A patent/KR100479149B1/ko not_active IP Right Cessation
- 1997-12-04 NZ NZ335879A patent/NZ335879A/xx unknown
- 1997-12-04 ES ES97949758T patent/ES2264174T3/es not_active Expired - Lifetime
- 1997-12-04 BR BR9714376A patent/BR9714376A/pt unknown
- 1997-12-04 JP JP52580198A patent/JP4124820B2/ja not_active Expired - Lifetime
- 1997-12-04 DE DE69736193T patent/DE69736193T2/de not_active Expired - Lifetime
- 1997-12-04 RU RU99114018/04A patent/RU2179172C2/ru not_active IP Right Cessation
- 1997-12-04 CA CA002274144A patent/CA2274144C/en not_active Expired - Lifetime
- 1997-12-04 EP EP97949758A patent/EP0956296B1/en not_active Expired - Lifetime
- 1997-12-04 WO PCT/US1997/022251 patent/WO1998024807A2/en active IP Right Grant
-
2007
- 2007-12-11 JP JP2007319238A patent/JP4264762B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE69736193D1 (de) | 2006-08-03 |
| WO1998024807A2 (en) | 1998-06-11 |
| HUP0003396A1 (hu) | 2001-02-28 |
| EP0956296A2 (en) | 1999-11-17 |
| AU7624898A (en) | 1998-06-29 |
| DE69736193T2 (de) | 2007-05-03 |
| KR100479149B1 (ko) | 2005-03-25 |
| TW575582B (en) | 2004-02-11 |
| JP4124820B2 (ja) | 2008-07-23 |
| PL334089A1 (en) | 2000-01-31 |
| IL130166A0 (en) | 2000-06-01 |
| JP2008120818A (ja) | 2008-05-29 |
| AU728224B2 (en) | 2001-01-04 |
| ATE330966T1 (de) | 2006-07-15 |
| BR9714376A (pt) | 2000-03-21 |
| EP0956296B1 (en) | 2006-06-21 |
| CA2274144A1 (en) | 1998-06-11 |
| MXPA99004944A (es) | 2004-09-10 |
| CA2274144C (en) | 2004-03-30 |
| RU2179172C2 (ru) | 2002-02-10 |
| JP4264762B2 (ja) | 2009-05-20 |
| NZ335879A (en) | 2000-11-24 |
| JP2001505580A (ja) | 2001-04-24 |
| WO1998024807A3 (en) | 1998-10-15 |
| ES2264174T3 (es) | 2006-12-16 |
| KR20000069243A (ko) | 2000-11-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP9901455A3 (en) | Somatostatin peptides | |
| IL112903A0 (en) | GnRH antagonist peptides | |
| PL344341A1 (en) | Peptides | |
| HRP970308B1 (en) | Peptide derivatives | |
| IL125804A0 (en) | Peptide derivatives | |
| HUP0003396A3 (en) | Somatostatin antagonist peptides | |
| GB9718110D0 (en) | Peptides | |
| GB9825854D0 (en) | Peptide | |
| GB9624562D0 (en) | Peptide derivatives | |
| GB9700154D0 (en) | Peptides | |
| GB9812675D0 (en) | Peptides | |
| EP0996457A4 (en) | PEPTIDES RELEASERS OF F.S.H. | |
| IL127565A0 (en) | Virginiamycin mixture | |
| ZA965538B (en) | Somatostatin peptides. | |
| NZ314277A (en) | Octopeptide somatostatin antagonist | |
| GB9807890D0 (en) | Peptides | |
| ZA981891B (en) | Peptides useful as somatostatin antagonists. | |
| GB9613705D0 (en) | Novel peptides | |
| SI0835263T1 (en) | Somatostatin peptides | |
| GB9622890D0 (en) | Peptide compounds | |
| GB9625227D0 (en) | Peptides | |
| GB9608430D0 (en) | Peptides | |
| GB9606765D0 (en) | Peptides | |
| SG55039A1 (en) | Peptides | |
| GB9626362D0 (en) | Peptides |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |